Jun Cheng

569 total citations
33 papers, 453 citations indexed

About

Jun Cheng is a scholar working on Molecular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Jun Cheng has authored 33 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Medicine, 10 papers in Molecular Biology and 9 papers in Infectious Diseases. Recurrent topics in Jun Cheng's work include Antibiotic Resistance in Bacteria (16 papers), Bacterial biofilms and quorum sensing (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jun Cheng is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Bacterial biofilms and quorum sensing (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Jun Cheng collaborates with scholars based in China. Jun Cheng's co-authors include Lifen Hu, Jia-Bin Li, Yanyan Liu, Haifei Yang, Ying Ye, Guohua Liu, Liang Zhong, Tao Du, Yingjian Zhu and Yulin Zhu and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Jun Cheng

32 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Cheng China 13 191 135 86 85 80 33 453
Mehrez M. Jadaon Kuwait 10 174 0.9× 105 0.8× 86 1.0× 23 0.3× 19 0.2× 16 457
Harunur Rashid Bangladesh 15 72 0.4× 268 2.0× 106 1.2× 32 0.4× 27 0.3× 44 664
Win Win Maw Japan 12 64 0.3× 116 0.9× 32 0.4× 37 0.4× 28 0.3× 28 518
Vasiliki Koumaki Greece 12 412 2.2× 106 0.8× 184 2.1× 13 0.2× 124 1.6× 41 615
Sonia Gómez Argentina 21 403 2.1× 248 1.8× 362 4.2× 24 0.3× 97 1.2× 59 1.1k
Dieter Klarmann Germany 11 49 0.3× 38 0.3× 37 0.4× 70 0.8× 42 0.5× 27 428
Victoria Holden United States 8 181 0.9× 209 1.5× 103 1.2× 13 0.2× 25 0.3× 11 502
Ioannis Neonakis Greece 16 246 1.3× 223 1.7× 90 1.0× 15 0.2× 71 0.9× 43 872
Mabel Woloj United States 10 96 0.5× 65 0.5× 178 2.1× 33 0.4× 49 0.6× 14 415
Melika Moradi Iran 13 133 0.7× 141 1.0× 64 0.7× 8 0.1× 28 0.3× 29 500

Countries citing papers authored by Jun Cheng

Since Specialization
Citations

This map shows the geographic impact of Jun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Cheng more than expected).

Fields of papers citing papers by Jun Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Cheng. The network helps show where Jun Cheng may publish in the future.

Co-authorship network of co-authors of Jun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Cheng. A scholar is included among the top collaborators of Jun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Cheng. Jun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Jun, et al.. (2024). HCV Reactivation in a Patient with Hepatocellular Carcinoma Due to Sorafenib: A Case Report. International Medical Case Reports Journal. Volume 17. 121–124.
2.
Yin, Jun, Wen Meng, Jun Cheng, et al.. (2022). A Patient With Failed Liver Transplantation After the Use of PD-1 Blockade Combined With Lenvaxen. Frontiers in Medicine. 9. 712466–712466. 6 indexed citations
3.
Sun, Juan, et al.. (2022). Malignant melanoma mimic fungal infection a case report. Diagnostic Pathology. 17(1). 33–33. 4 indexed citations
4.
Zheng, Yun, et al.. (2021). Acetylation of histone 3 promotes miR-29a expression and downregulates STAT3 in sepsis. Injury. 53(2). 416–421. 3 indexed citations
5.
Xue, Jihua, et al.. (2021). Role of Ras-related Nuclear Protein/Polypyrimidine Tract Binding Protein in Facilitating the Replication of Hepatitis C Virus. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
6.
Yang, Haifei, Guosheng Chen, Lifen Hu, et al.. (2016). Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model. Journal of Microbiology Immunology and Infection. 51(1). 70–75. 28 indexed citations
7.
Wang, Jianguo, Xuanyu Zhang, Xuyong Wei, et al.. (2015). Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma. PLoS ONE. 10(12). e0144216–e0144216. 15 indexed citations
8.
Mei, Qing, Ying Ye, Yulin Zhu, et al.. (2015). Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 45(6). 652–656. 10 indexed citations
9.
Cheng, Jun, et al.. (2014). Hepatic encephalomyelopathy: a complication following liver cirrhosis caused by Budd-Chiari syndrome and HBV. The Journal of Infection in Developing Countries. 8(4). 551–553. 1 indexed citations
10.
Mei, Qing, et al.. (2014). Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin. European Journal of Clinical Microbiology & Infectious Diseases. 34(4). 737–744. 15 indexed citations
11.
Yang, Haifei, Aijun Pan, Lifen Hu, et al.. (2014). Galleria mellonella as an in vivo model for assessing the efficacy of antimicrobial agents against Enterobacter cloacae infection. Journal of Microbiology Immunology and Infection. 50(1). 55–61. 25 indexed citations
12.
Yang, Haifei, Guosheng Chen, Yulin Zhu, et al.. (2013). Surveillance of Antimicrobial Susceptibility Patterns among Shigella Species Isolated in China during the 7-Year Period of 2005-2011. Annals of Laboratory Medicine. 33(2). 111–115. 27 indexed citations
14.
Zhu, Yulin, Haifei Yang, Yanyan Liu, et al.. (2013). Detection of plasmid-mediated quinolone resistance determinants and the emergence of multidrug resistance in clinical isolates of Shigella in SiXian area, China. Diagnostic Microbiology and Infectious Disease. 75(3). 327–329. 13 indexed citations
15.
Zhu, Yulin, Qing Mei, Lifen Hu, et al.. (2012). Vancomycin MICs of the resistant mutants of S. aureus ATCC43300 vary based on the susceptibility test methods used. The Journal of Antibiotics. 65(6). 307–310. 1 indexed citations
16.
Hu, Lifen, et al.. (2012). Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin. Journal of Antimicrobial Chemotherapy. 67(11). 2700–2706. 28 indexed citations
17.
Cheng, Jun, Qian Wang, Yan Chen, et al.. (2009). Phenotypic and molecular characterization of a novel β-lactamase carried by Klebsiella pneumoniae, CTX-M-72, derived from CTX-M-3. The Journal of General and Applied Microbiology. 55(3). 207–216. 4 indexed citations
18.
Cheng, Jun, Wei Gao, Jun Yin, et al.. (2009). Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae. Molecular Biology Reports. 37(3). 1261–1267. 7 indexed citations
19.
Wang, Qian, Jun Cheng, Yan Chen, et al.. (2008). Characterization of a Novel AmpC-Type Plasmid-Mediated β-Lactamase from an Escherichia coli Strain Isolated in China. Current Microbiology. 57(6). 558–563. 1 indexed citations
20.
Cheng, Jun, Ying Ye, Yingying Wang, et al.. (2008). Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli. Acta Pharmacologica Sinica. 29(2). 217–225. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026